Cargando…
Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324157/ https://www.ncbi.nlm.nih.gov/pubmed/30574948 http://dx.doi.org/10.4103/ijo.IJO_1740_18 |
| _version_ | 1783385924430725120 |
|---|---|
| author | Padhi, Srikant Kumar, Vinod |
| author_facet | Padhi, Srikant Kumar, Vinod |
| author_sort | Padhi, Srikant |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6324157 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63241572019-01-25 Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy Padhi, Srikant Kumar, Vinod Indian J Ophthalmol Letters to the Editor Medknow Publications & Media Pvt Ltd 2019-01 /pmc/articles/PMC6324157/ /pubmed/30574948 http://dx.doi.org/10.4103/ijo.IJO_1740_18 Text en Copyright: © 2018 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letters to the Editor Padhi, Srikant Kumar, Vinod Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy |
| title | Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy |
| title_full | Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy |
| title_fullStr | Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy |
| title_full_unstemmed | Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy |
| title_short | Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy |
| title_sort | response to comment on: dramatic response to intravitreal bevacizumab in hypertensive retinopathy |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324157/ https://www.ncbi.nlm.nih.gov/pubmed/30574948 http://dx.doi.org/10.4103/ijo.IJO_1740_18 |
| work_keys_str_mv | AT padhisrikant responsetocommentondramaticresponsetointravitrealbevacizumabinhypertensiveretinopathy AT kumarvinod responsetocommentondramaticresponsetointravitrealbevacizumabinhypertensiveretinopathy |